A detailed history of Braidwell LP transactions in Hille Vax, Inc. stock. As of the latest transaction made, Braidwell LP holds 1,064,000 shares of HLVX stock, worth $1.95 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,064,000
Holding current value
$1.95 Million
% of portfolio
0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.58 - $14.42 $1.68 Million - $15.3 Million
1,064,000 New
1,064,000 $1.87 Billion
Q4 2023

Feb 14, 2024

SELL
$10.35 - $17.11 $12.9 Million - $21.3 Million
-1,245,839 Reduced 85.96%
203,407 $3.26 Billion
Q3 2023

Nov 14, 2023

BUY
$11.59 - $16.7 $2.32 Million - $3.34 Million
200,000 Added 16.01%
1,449,246 $19.5 Billion
Q2 2023

Aug 14, 2023

SELL
$12.93 - $18.76 $4.8 Million - $6.96 Million
-370,970 Reduced 22.9%
1,249,246 $21.5 Billion
Q4 2022

Feb 14, 2023

BUY
$13.52 - $21.46 $21.9 Million - $34.8 Million
1,620,216 New
1,620,216 $27.1 Billion

Others Institutions Holding HLVX

About HilleVax, Inc.


  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $61.2M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track Braidwell LP Portfolio

Follow Braidwell LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.